Athersys
Share
Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class th
Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical conditions where there is significant unmet clinical need, and we are particularly focused on developing therapies in the regenerative medicine area. We are developing MultiStem®, a patented, a
11/17/2023
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announce
10/16/2023
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) fo
10/10/2023
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, a
10/06/2023
We're excited for Alliance for Regenerative Medicine's next week! Looking forward to connecting with senior executives and key stakeholders in the cell and gene therapy industry.
Cell & Gene Meeting on the Mesa The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
10/03/2023
Athersys Licenses its Animal Health Assets to Ardent Animal Health
Athersys Licenses its Animal Health Assets to Ardent Animal Health Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, a
10/03/2023
We are excited to announce that Jane Wasman, JD, has been appointed Athersys Board Chair. Read more here: https://buff.ly/3F2IxB0
09/28/2023
We hosted our 2023 Annual Meeting of Stockholders yesterday. In case you missed it, you can listen to a replay here -
ATHERSYS, INC.'s Virtual Shareholder's Meeting - Thank you page ATHERSYS, INC.'s meeting has concluded. A replay will be available in 24 hours at: www.virtualshareholdermeeting.com/ATHX2023
09/27/2023
Our Annual Meeting will begin at 8:30 a.m. ET this morning. Stockholders and guests can join beginning now here:
ATHERSYS, INC.'s Virtual Shareholder's Meeting - Login page Please complete the required fields below to access the meeting as a stockholder. For assistance, please call Phone number844-986-0822 (US) or Phone number303-562-9302 (International).
09/26/2023
Tomorrow is our Annual Meeting of Stockholders. The meeting will begin at 8:30 a.m. ET. If you're a stockholder, please have your control number ready. Both stockholders and guests can join 15 minutes prior to the start of the meeting.
ATHERSYS, INC.'s Virtual Shareholder's Meeting - Pre meeting message page ATHERSYS, INC. is hosting a Virtual Stockholder Meeting on Wednesday, September 27, 2023 at 08:30 AM, Eastern Time, and the stockholders of record will be able to vote and ask questions online during the meeting. If you would like to attend the virtual meeting and have your control number, please lo...
09/25/2023
The American Stroke Association has a number of great resources for stroke patients and caregivers, including a directory of local support groups. Find the support group nearest to you here: https://buff.ly/3LzV7LP
09/22/2023
Reminder: Our Annual Meeting of the Stockholders is next Wednesday, September 27th at 8:30 a.m. ET. This meeting will be open to both stockholders and guests. If you are a stockholder and wish to vote during the meeting, you will need to join with your control number.
If you have questions in advance of the meeting, please reach out to [email protected].
Athersys, Inc. - Investors - Resources - Annual Information The 2023 Annual Meeting of Stockholders will be a virtual meeting and stockholders can participate online at http://www.virtualshareholdermeeting.com/ATHX2023 on September 27, 2023 at 8:30 AM Eastern Time. To attend the Annual Meeting, you will need the 16-digit control number located on your prox...
Click here to claim your Sponsored Listing.
Contact the practice
Website
Address
3201 Carnegie Avenue
Cleveland, OH
44115